Ildong's Samion likely to get more sales

Published: 2008-03-03 06:57:00
Updated: 2008-03-03 06:57:00
Ildong Pharm's Samion (nicergolin), cererovascular medine, is expected to increase as leading ginkgo biloba preparations Ginexin and Tanamin will be non-eligible for health insurance from this May.

Ildong garnered 16.5 billion won in Samion sales last year.

Most of nicergolin drug makers ...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.